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Abstract
Objective: To describe the epidemiology of health status, impairments, activities and participation in adults with cerebral palsy (CP).
Data Sources: Embase, MEDLINE, Web of Science, PsycINFO, Cumulative Index to Nursing and Allied Health, Cochrane, and Google Scholar
were searched for 3 themes (“cerebral palsy,” “adult,” and “outcome assessment”) in literature published between January 2000 and
December 2018.
Study Selection: Full-article peer-reviewed English journal articles on descriptive, observational, or experimental studies describing the most
studied outcomes in adults with CP (n25, age18y) were included. Studies were included in the analyses if frequently studied outcomes were
described in at least 3 studies using similar methods of assessment.
Data Extraction: Data were extracted independently by 2 authors from 65 articles (total NZ28,429) using a standardized score sheet.
Data Synthesis: Meta-analyses revealed that overall, on average 65.1% (95% confidence interval [CI], 55.1-74.5) of adults with CP experienced
pain, 57.9% (95% CI, 51.1-64.6) were ambulant, 65.5% (95% CI, 61.2-69.7) had little or no limitation in manual ability, 18.2% (95% CI, 10.6-
27.2) had tertiary education, 39.2% (95% CI, 31.5;47.1) were employed, and 29.3% (95% CI, 9.0-55.3) lived independently. In adults without
intellectual disability, proportions of individuals who were ambulant (72.6% [95% CI, 58.8-84.5]) and lived independently (90.0% [95% CI, 83.8-
94.9]) were higher (PZ.014 and P<.01, respectively). The Fatigue Severity Scale score was 4.1 (95% CI, 3.8-4.4). Epilepsy (28.8% [95% CI,
20.1-38.4]) and asthma (28.3% [95% CI, 18.7-38.9]) were especially prevalent comorbidities.
Conclusions: The present systematic review and meta-analysis on the epidemiology of adults with CP provided state-of-the-art knowledge on the
most frequently studied outcomes. On average, adults with CP are fatigued, and a majority experience pain, are ambulant, and have little or no
difficulty with manual ability. On average, 40% are employed and 30% live independently. More uniformity in assessment and reports is advised
to improve knowledge on epidemiology and gain insight in more outcomes.
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ª 2020 by the American Congress of Rehabilitation MedicineCerebral palsy (CP) is an umbrella-term describing “a group of
permanent disorders of the development of movement and
posture, causing activity limitation, that are attributed to nonpro-
gressive disturbances that occurred in the developing fetal or
infant brain. The motor disorders of cerebral palsy are oftenSupported by Rijndam Rehabilitation, Rotterdam, The Netherlands.
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https://doi.org/10.1016/j.apmr.2020.01.009accompanied by disturbances of sensation, perception, cognition,
communication and behavior, by epilepsy and by secondary
musculoskeletal problems”1(p9) and it affects 2 to 2.5 per 1000 live
births.1-4 Approximately three-fourths of persons with CP are
adults (ie, 18 years or older).5
In the past decades, attention for adults with CP in rehabili-
tation practice and research increased.6 Aging with CP comes with
several issues in health and functioning. Recently, several
comorbidities were increased in adults with CP, including asthmahabilitation Medicine
2 M. van Gorp et aland hypertension.7,8 Pain and fatigue are common in adults with
CP,9 and pain, mobility, and self-care deteriorate over time.10,11 In
addition, young adults with CP are less often employed or live
independently than young adults without CP.12,13 Moreover,
activity limitations and difficulty in participation increase
with aging.10,14
Common impairments and functional limitations in children
with CP were previously studied in a systematic review,15 but
systematic knowledge on adults with CP is scarce. Because dif-
ferences were found in epidemiology between children and adults
with CP,16 results cannot be extrapolated to the adult CP popu-
lation. Insight into the prevalence of impairments and level of
functioning in adults with CP would be helpful to guide rehabil-
itation follow-up programs. In addition, such insight would
contribute to a better understanding of the effect of CP at adult
age. Therefore, this review and meta-analysis aims to describe the
health status, prevalence of impairments, and level of activities
and participation of adults with CP using published literature. We
focused on the most frequently studied outcomes in adults with CP
from the literature, which were reported in a recently published
review by Benner et al.6Methods
Search strategy
The search strategy, which was developed in consultation with an
information specialist, was used in 7 databases (Embase, MED-
LINE, Web of Science, PsycINFO, Cumulative Index to Nursing
and Allied Health, Cochrane, and Google Scholar) and consisted
of 3 themes (“cerebral palsy,” “adult,” and “outcome assess-
ment”). Key terms were mapped to controlled headings and
expanded to include free text terms, tailored to the specific data-
base. See Benner et al for the complete search strategy.6 Literature
was searched from 2000 through 2018 because the search used in
Benner et al was updated with publications from 2017 and 2018.
After deduplication, all publications were screened for eligibility
on title and abstract and subsequently full text by 2 independent
reviewers (J.B., S.N. for publications in 2000-2016; M.vG., S.H.
for 2017-2018), disagreements were discussed and resolved
between the 2 reviewers. If disagreement remained this was
discussed with a third reviewer (M.R.) to reach consensus.Eligibility criteria
Studies were included if they met the following criteria: (1) They
reported on the most frequently studied outcomes according to the
systematic review of Benner et al.6 From this list of outcomesList of abbreviations:
BMI body mass index
CI confidence interval
CP cerebral palsy
FSS Fatigue Severity Scale
GMFCS Gross Motor Function Classification System
ICF International Classification of Functioning,
Disability and Health
ID intellectual disability
MACS Manual Ability Classification System
SF-36 Short Form-36 Health Surveysingle-item outcomes (eg, pain) were selected if at least 10 studies
provided information on this outcome; multi-item outcomes (eg,
Fatigue Severity Scale [FSS]) were selected if at least 5 studies
provided information. (2) At least 3 studies reported on an
outcome using similar methods of assessment, enabling compar-
ison and meta-analysis. (3) Study design was descriptive, obser-
vational, or experimental. Meta-analyses, reviews, case studies,
qualitative studies, comments, and study protocols were excluded.
(4) They were full-article peer-reviewed journal articles written in
English. (5) They described individuals with CP only or in case-
control design. (6) They described 25 adults who were 18
years or older at the time of the first measurement or at follow-up.
Studies describing both children and adults with CP were included
when at least 50% of the sample were adults. (7) They reported on
outcomes of functioning, excluding studies reporting on evalua-
tions of services, for example, evaluation of transition services or
complications and adverse events during or after surgery. (8)
Study samples were population based or rehabilitation based, or
samples addressed a substantial subgroup of individuals with CP
(eg, Gross Motor Function Classification System [GMFCS] I-III,
bilateral spastic CP, dyskinetic CP). Nonrepresentative samples
that consisted of adults selected because of having specific im-
pairments (eg, pain, fatigue, incontinence) or because of previous
operations (eg, selective dorsal rhizotomy, constructive hip oper-
ations) were excluded. For intervention studies, only baseline
observations were included. When outcomes were reported in
multiple publications on the same study sample, the most recently
observed outcome was included.
Outcomes
Frequently studied outcomes identified by Benner et al were
grouped in line with the International Classification of Func-
tioning, Disability, and Health (ICF) as health status, impairments,
or activities and participation, with the first group encompassing
outcomes that were not covered by the ICF or were linked to more
than 1 component.6,17 These outcomes are depicted in the first
column of Table 1. Health status outcomes addressed weight
status (body mass index [BMI, calculated as weight in kilograms
divided by height in meters squared], obesity), fat mass (waist
circumference), comorbidities, and the domains of the Short
Form-36 Health Survey, (SF-36) (scale range 0-100, with the
physical health component score on a T score metric with a mean
of 50 and SD of 10 for the US general population).78 Comor-
bidities included epilepsy, diabetes, hypertension, asthma, stroke,
heart disease, and osteoarthritis. The impairments addressed pain
(presence of any pain, including the outcomes pain in joints and
pain in body part6), fatigue (assessed using the FSS, scale range
1-7)79 and mobility of joints (limited range of motion in knee or
hip). Outcomes referring to the level of activities and participation
were walking status (ambulant with or without assistive device as
primary method of mobility in daily life), which included the
outcomes walking or moving around using assistive devices and
assistive devices for mobility6), fine hand use (Manual Ability
Classification System [MACS] level I or II, manual ability),80
education status (attending or completing tertiary education
according to the international standard classification of education;
ie, higher education, college and university),81 employment status
(having remunerative employment), living status (living inde-
pendently), and activities and social roles, assessed using the
Assessment of Life Habits questionnaire, Life-H (scale range
0-9).82 Although frequently studied according to Benner et al,6 wewww.archives-pmr.org
Table 1 Characteristics of included studies
Author* Countryy N ID (%) GMFCS I-III (%) Age (y), Mean (Range) % Male
Ballester-Plané et al18 Spaina 52 Mixed 56 25 (7-62) 54
Laporta-Hoyos et al19 Spaina 39 Mixed 64 21 (6-62) 51
Whitney et al20 USAb 1395 Mixed 54 18 to >50 48
Whitney et al8 USAb 452 Mixed 51 24 (18-30) 43
Cremer et al21 USAb 435 Mixed 54 50 (40-60) 46
Cremer et al a21 USAb 201 Mixed 55 48 (40-60) 100
Cremer et al b21 USAb 234 Mixed 53 50 (40-60) 0
Ágústsson et al22 Swedenc 830 Mixed 57 23 (16-73) 56
Alriksson-Schmidt et al23 Swedenc 102 Mixed 72 21 (18-24) 62
Rodby-Bousquet et al24 Swedenc 102 Mixed 72 21 (19-23) 62
van Gorp et al a25 The Netherlandsd 67 31 67 25 (21-27) 67
van Gorp et al b25 The Netherlandsd 54 0 82 32 (29-34) 54
van Meeteren et al26 The Netherlandsd 83 0 87z 20 (18-22) 59
Nieuwenhuijsen et al27 The Netherlandsd 87 0 90 20 (18-22) 59
Benner et al10 The Netherlandse 49 22 80 40 (34-45) 55
Benner et al12 The Netherlandse 49 22 80 40 (34-45) 55
van der Dussen et al28 The Netherlandse 80 28 71x 21-31 51
Kirk et al a29 Denmarkf 22 Mixed 100 34 (18-57) 68
Kirk et al b29 Denmarkf 22 Mixed 100 37 (18-59) 55
McPhee et al30 Canadag 42 Mixed 57 34 (18-75) 50
McPhee et al31 Canadag 42 Mixed 57 34 (18-75) 50
Slaman et al a32 The Netherlandsh 28 0 100 20 (16-24) 43
Slaman et al b32 The Netherlandsh 29 0 98 20 (16-24) 52
Russchen et al33 The Netherlandsh 56 0 100 20 (16-24) 48
Slaman et al34 The Netherlandsh 57 0 98 20 (16-24) 47
Ryan et al35 Ireland 55 Mixed 75 38 (18-65) 56
Morgan et al36 Australia 34 0 100 44 (26-65) 44
Morgan et al37 Australia 25 16 100 41 (30-65) 36
Reddihough et al38 Australia 335 50 63 25 (20-30) 51
van der Slot et al39 The Netherlandsi 43 0 95 37 (25-45) 63
van der Slot et al a39 The Netherlandsi 27 0 95 37 (25-45) 100
van der Slot et al b39 The Netherlandsi 16 0 95 37 (25-45) 0
van der Slot et al40 The Netherlandsi 56 0 93 36 (25-45) 63
van der Slot et al41 The Netherlandsi 56 0 93 36 (25-45) 63
van der Slot et al a41 The Netherlandsi 35 0 93 36 (25-45) 100
van der Slot et al b41 The Netherlandsi 21 0 93 36 (25-45) 0
Opheim et al42 Norwayj 149 0 93 40 (24-76) 51
Opheim et al11 Norwayj 149 0 93 40 (24-76) 51
Jahnsen et al43 Norwayj 406 0 78x 34 (18-72) 51
Jahnsen et al44 Norwayj 406 0 78x 34 (18-72) 51
Jahnsen et al45 Norwayj 766 0 Mixed 34 (18-72) 52
Maltais et al46 Canada 132 Mixed 60 28 (20-41) 50
Michelsen et al47 Denmarkk 416 20 88x 32 (29-35) 58
Michelsen et al48 Denmarkk 819 20 84x 29 (21-35) 58
Engel et al49 USA 100 0 18 38 (19-71) 55
Fortuna et al7 USA 229 54 55x 18 to >60 59
Gillet et al50 Australia 33 Mixed 100z 25 (15-51) 55
Lundh et al51 Sweden 50 Mixed 100 32 (22-67) 54
Park et al52 USA 229 0k 51 40 (20-69) 60
Peterson et al53 USA 2659 Mixed Mixed Median (IQR): 36 (25-48) 52
Sienko et al54 USA 97 41{ 65 24 (18-30) 48
Smith et al55 UK 1705 21 Mixed 3316 53
Daunter et al56 USA 50 0k 70 27 (18-35) 48
de Albuquerque Botura et al57 Brazil 93 Mixed 0 18-57 56
Hayward et al58 USA 375 24{ 63 36 (18-76) 0
Park et al59 Korea 53 Mixed 63z 3114 62
Vukojevic et al60 Bosnia and Herzegovina 100 55 Mixed 18-58 62
(continued on next page)
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Author* Countryy N ID (%) GMFCS I-III (%) Age (y), Mean (Range) % Male
Yildiz et al61 Turkey 117 26# 74 25 (18-62) 55
Brunton et al62 Canada 111 0k 78 19 (14-31) 50
Peterson et al63 USA 1015 Mixed Mixed 58 (57-60) 66
Peterson et al64 USA 112 Mixed 52 3413 46
Huang et al65 Taiwan 279 28 50x 26 (20-40) 61
Nedjad et al66 Sweden 156 62{ 27x 37 (19-43) 55
Mesterman et al67 Israel 95 35 83x 23 (18-30) 61
Gaskin et al68 Australia 51 0 45 38 (19-66) 63
Andersson et al a69 Sweden 13 0 100 36 (26-58) 64
Andersson et al b69 Sweden 12 0 100 36 (26-58) 64
Sandstrom et al70 Sweden 48 20{ 71 33 (20-?) 48
Strauss et al71 USA 14,806 Mixed 62x 20-85 53
Andersson et al72 Sweden 221 0 Mixed 36 (20-58) 57
Bottos et al73 Italy 72 41 76x 33 (19-65) 60
Furukawa et al74 Japan 81 Mixed 73x 36 (26-57) 44
Hodgkinson et al75 France 234 Mixed 0 28 (15-?) 59
Maruishi et al76 Japan 256 43 Mixed 32 (17-83) 55
Murphy et al77 USA 101 Mixed Mixed 43 (19-74) 52
NOTE. Mixed: no exact proportion reported, also no in- or exclusion criteria regarding cognition or mobility.
Abbreviation: IQR, interquartile range.
* Letters a or b after the authors name (ie, Cremer et al a) indicate subsamples of 1 publication.
y Letters indicate publications on the same study sample in a country.
z Proportion of GMFCS level I and II.
x No GMFCS level reported; proportion walking with or without walking aid.
k Those unable to complete questionnaires were excluded.
{ Proportion proxy report.
# Proportion illiterate, but individuals with severe cognitive impairments were excluded.
4 M. van Gorp et aldid not estimate overall results for the following outcomes
because these were only reported in 1 or 2 included studies using a
similar assessment method: spasticity, muscle power, hip
displacement, gait pattern, speech, spinal deformities of thoracic,
lumbar and sacral column, Barthel Index,83 FIM,84 Gross Motor
Function Measure,85 Functional Mobility Scale,86 and Japanese
Orthopaedic Association Score.87Data extraction
A standardized data extraction record sheet was used to collect
study sample characteristics and outcomes. Sample characteristics
included country, sample size, sex, age, proportion with intellec-
tual disability (ID), and proportion with level of GMFCS I-III.88
Studies including any proportion of individuals with ID or those
that did not mention exclusion based on intellectual function,
suggesting individuals with ID could be part of the sample, were
reported as mixed samples. Studies including only individuals
without ID are further referred to as no ID samples. With respect
to the outcomes, the method of assessment and the outcome
(proportion [%], or mean/median scores [SD/interquartile range])
were noted.Analysis
Overall results with corresponding 95% confidence intervals (CIs)
were estimated using meta-analysis models. Overall mean pro-
portions and means were estimated with a random-effects meta-
analysis model using the DerSimonian and Laird estimator.89 TheFreeman-Tukey double arcsine transformation was used on pro-
portions.90,91 Means were analyzed untransformed. Meta-analysis
modeling was done using the metaprop and metamean functions
of the meta package in R 3.2.5.a The random-effects model takes
the heterogeneity of samples into account. Statistical heteroge-
neity was quantified using the I2 measure, which describes the
amount of variation attributed to heterogeneity rather than sam-
pling error across samples.92 Subgroup analyses of mixed and no
ID samples were conducted, if multiple studies of mixed and no
ID samples were available, for outcomes on activities and
participation because ID is known to be strongly related to these
outcomes.25,93 A random-effect Q test was used to test differences
between mixed and no ID samples. Sensitivity analyses excluded
specific subsamples of the population with CP from analyses if
substantial deviations in the outcome could be explained by
sample characteristics. These samples were for manual ability: a
no ID sample25 and a sample with only individuals with dyskinetic
subtype,19 for epilepsy: a no ID sample52 and a sample with only
individuals with GMFCS level IVand V,57 and for living situation:
a young sample (mean age, 20y).27 Results of sensitivity analyses
showed substantial influence of deviating samples, which were
therefore excluded in the estimation of overall proportions and
means; outcomes of the excluded studies were displayed in the
forest plots.Results
After deduplication, the initial search revealed 6662 publications
(fig 1). After screening by title and abstract, 810 full-text articleswww.archives-pmr.org
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Fig 1 Flow diagram of study selection process.
Epidemiology of CP in adulthood 5were assessed for eligibility. Finally, 65 articles (total NZ28,429)
were included in the meta-analyses, meaning these reported 1 or
more of the selected outcomes comparable to at least 2 other
studies. Table 1 displays the characteristics of the studies used in
the meta-analyses. Of the samples, 73% were mixed and 27%
were no ID. The mean age of the study samples was 32 years,
samples consisted on average of 68% individuals with GMFCS
level I-III and 53% were male. Table 2 shows the overall pro-
portion and/or mean for each of the outcomes, and fig 2 and
supplemental appendix S1 (available online only at http://www.
archives-pmr.org/) show the forest plots of these analyses. The
level of heterogeneity (I2) was substantial (>75%) for most of the
analyses, reflecting considerable variation in results between
studies (see fig 2, supplemental appendix S1).
Health status
Mean overall BMI was 25.1 (95% CI, 23.8-26.5), and 22.6% (95%
CI, 14.7-31.5) of individuals with CP were obese (BMI>30).
Epilepsy (28.8% [95% CI, 20.0-38.4]), asthma (28.3% [95% CI,
18.7-38.9]), and hypertension (21.6% [95% CI: 15.6; 28.4]) were
the most prevalent comorbidities. The overall estimated mean SF-
36 physical component score was 44.6 (95% CI, 40.7-48.5).
Impairments
Overall presence of pain was estimated at 65.1% (95% CI, 55.1-
74.5). For fatigue, the overall estimated mean FSS score was 4.1
(95% CI, 3.8-4.4). Limitations in knee and hip mobility were
estimated to be present in 39.5% (95% CI, 21.1-59.5) and 33.4%
(95% CI, 15.1-54.6) of adults with CP, respectively.
Level of activities and participation
A majority of adults with CP in mixed samples were estimated to
be ambulatory (57.9% [95% CI, 51.1-64.6]) and to have little or
no limitation in manual ability (MACS level I or II, 65.5% [95%
CI, 61.2-69.7]). The proportion of ambulatory individuals seemedwww.archives-pmr.orghigher in the 2 no ID samples (72.6% [95% CI, 58.8-84.5], Q:
3.60, PZ.058). Analyses on additional outcomes of those ambu-
latory included all samples, regardless of ID. Among ambulatory
individuals, 31.9% (95% CI, 22.2-42.4) used an assistive device,
and 56.2% (95% CI, 37.0-74.5) had reported to perceive a decline
in walking function or capacity over time. The overall mean re-
sults on the 6-minute walk test of ambulatory adults with CP was
387.9 m (95% CI, 328.5-447.3).
Reports of attendance of tertiary education were remarkably
similar between mixed samples and no ID samples (Q: 1.03,
PZ0.311, overall result: 18.2% [95% CI, 10.6-27.2]). The mean
estimated proportion of adults with CP with remunerative
employment tended to be lower in mixed samples (39.2% [95%
CI, 31.5-47.1]) than in no ID samples (56.0% [95% CI, 31.7-78.9],
Q: 1.64, PZ.200). A large difference (Q: 22.11, P<0.01) was
found in the proportions living independently between mixed
samples (29.3% [95% CI, 9.0; 55.3]) and no ID samples (90.0%
[95% CI, 83.8; 94.8]). Only used in no ID samples, the overall
estimated mean Life-H activities score was 8.0 (95% CI, 7.5-8.4),
and the social roles score was 8.2 (95% CI, 7.9-8.4).Discussion
This systematic review and meta-analysis estimated overall health
status, and rates of impairments, activities, and participation of adults
with CP for the most studied outcomes in the available literature ac-
cording to a recent systematic review by Benner et al.6 This provides
state-of-the-art knowledge for this population on a range of topics,
such as pain, walking status, living situation, and comorbidities based
on large accumulated samples combined fromstudiesacross theglobe.
Health status
Body composition and comorbidities that are known to be asso-
ciated with lifestyle, such as obesity, hypertension, and diabetes,
vary strongly across regions and age. The overall proportions
estimated in the present review are therefore difficult to compare
with general population data irrespective of age. Still, the overall
estimates that we provided for adults with CP provide a robust
indication of the occurrence of several comorbidities in the CP
adult population. Epilepsy is a known comorbidity of CP and is
included in its definition.1 The overall occurrence of 28.8% is
similar to that reported in a previous review of adults with CP and
the more recent review in children with CP.2,15 In addition, the
overall estimated occurrence of asthma in adults with CP (28.3%)
exceeds prevalence rates that were reported across the globe in
general populations (ranging from 1.0%-21.5%),94 suggesting that
asthma may be a common comorbidity in CP.
Impairments
Pain is the most frequently studied outcome in adults with CP.6
The estimated occurrence of pain (65%) is in line with another
recent review in adults with CP focusing on pain using individual
patient data (70%; 95% CI, 62-78)95 and seems to be more
prevalent compared with the general US population (56%).96 For
fatigue we estimated an overall score on the FSS over 4.0, which
is often used as a cutoff score indicating fatigue, implying that on
average adults with CP experience fatigue.97 A Swiss study found
a similar mean score for patients with a recent stroke and a lower
mean score (3.0) for healthy subjects without CP.97 Prevention and
Table 2 Meta-analyses results




or Mean (95% CI)
Health status
Body composition
Waist circumference (mean, in cm) 5 (31,34,35,39,64) 266 84.0 (82.2-85.7)
BMI (mean) 6 (21,31,33,35,39,64) 743 25.1 (23.8-26.5)
Obese (% BMI30) 7 (7,21,30,35,39,59,64) 968 22.6% (14.7-31.5)
Comorbidities (%)
Epilepsy 6 (7,10,18,55,60,73) 2189 28.8% (20.0-38.4)
Diabetes 7 (7,8,30,39,52,53,55,63) 6594 6.7% (3.8-10.3)
Hypertension 8 (7,8,30,39,52,53,59,63) 4646 21.6% (15.6-28.4)
Asthma 4 (7,8,21,63) 2076 28.3% (18.7-38.9)
Stroke 3 (8,21,63) 1847 2.0% (0.0-6.8)
Heart disease 3 (55,63,73) 2792 9.5% (5.1-15.0)
Osteoarthritis 3 (8,21,55) 2537 11.4% (2.0-26.9)
SF-36 (mean)
Samples without ID
Physical component 3 (36,41,42) 239 44.6 (40.7-48.5)
Physical function 4 (32,36,41,68) 197 53.9 (34.0-73.7)
Role physical 4 (32,36,41,68) 197 72.6 (67.7-77.6)
Role emotional 4 (32,36,41,68) 197 82.7 (77.9-87.5)
Vitality 4 (32,36,41,68) 197 56.9 (53.3-60.5)
Mental health 4 (32,36,41,68) 197 73.8 (71.6-76.0)
Social functioning 4 (32,36,41,68) 197 80.6 (76.5-84.6)
Bodily pain 5 (32,36,41,44,68) 599 70.3 (63.5-77.2)
General health 4 (32,36,41,68) 197 70.6 (67.2-73.9)
Impairments
Pain (%)
Presence of any pain 16 (10,24,40,44,49,51,54,56,57,59,62,66,70,72,74,76) 1836 65.1% (55.1-74.5)
Fatigue (mean)
Fatigue Severity Scale 5 (11,33,40,51,56) 352 4.1 (3.8-4.4)
Mobility of joints (%)
Limited knee mobility 3 (22,51,70) 928 39.5% (21.1-59.5)
Limited hip mobility 3 (22,51,70) 928 33.4% (15.1-54.6)
Activities and participation
Walking status
Ambulatory (%) - subgroup analysis:
Mixed samples 9 (7,10,46,65,67,71,73,74,77) 15839 57.9% (51.1-64.6)
Samples without ID 2 (43,72) 627 72.6% (58.8-84.5)
Ambulatory with assistive devices of
those ambulatory (%)
5 (43,65,72-74) 689 31.9% (22.2-42.4)
Perceived walking decline (%) 4 (11,36,37,46) 293 56.2% (37.0-74.5)
6MWT (mean, in m) 4 (29,37,50,69) 127 387.9 (328.5-447.3)
Manual ability (%)
No or little limitation (MACS
level I or II)
3 (23,25,58) 485 65.4% (61.1-69.6)
Education (%)




Mixed samples 9 (12,23,38,48,65,67,73,74,77) 1845 39.2% (31.5-47.1)
Samples without ID 4 (11,27,41,72) 437 56.0% (31.7-78.9)
Living status (%)
Living independently - subgroup
analysis:
Mixed samples 7 (23,38,47,67,71,73,77) 15927 29.3% (9.0-55.3)
Samples without ID 3 (11,41,72) 426 90.0% (83.8-94.8)
(continued on next page)
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or Mean (95% CI)
Activities and social roles
(mean score Life-H)
Activities domain
Samples without ID 3 (26,32,41) 198 8.0 (7.5-8.4)
Social roles domain
Samples without ID 3 (26,32,41) 198 8.2 (7.9-8.4)
Abbreviation: 6MWT, 6-minute walk test.
Epidemiology of CP in adulthood 7treatment of pain and fatigue are high priorities on a recent
patient-centered research agenda98 because literature on pain and
fatigue management and lifestyle strategies for this population is
scarce.32,99,100 Using insights from previous studies as a starting
point, such as discussing pain and fatigue management with adults
with CP and applying a multidimensional lifestyle intervention
program, future studies should aim to determine the effectiveness
of interventions reducing pain and fatigue.
We found that 1 in 3 adults with CP experience limited knee
and hip mobility. However, variation of these proportions were
very large, and few population-based studies were available that
reported joint mobility in adults with CP. Systematic knowledge of
joint mobility seems to be under-reported in current literature.
Similarly, other impairments that frequently occur in individuals
with CP, such as spasticity, hip displacement and spinal de-
formities, were not often reported on in population-representative
samples or lacked standardized assessments.2,15,22
Activities and participation
A majority of adults with CP were ambulatory (58%) and experi-
enced little or no difficulty with manual ability (65%). However, the
proportion of ambulant individuals is lower than that previously
reported in children with CP (72%).15 This is likely explained by a
decline in walking function as individuals with CP get older, which
we found to be experienced by half of the ambulant adults with CP.
The proportion of adults with CP who experienced little or no lim-
itation withmanual ability (65%) was very close to that reported in a
population-based study of children with CP (64%).101 This suggests
that althoughwalking ability declines in individualswithCP,manual
ability remains relatively stable in adulthood.
The overall proportions of adults with tertiary education
(18%), having remunerative employment (39%), and living
independently (29%) seem low but are very difficult to compare
with reference values because of regional differences and age-
specific participation rates, for example. Additionally, the varia-
tion between CP samples is also large, as shown by large statistical
heterogeneity (92%-99%), a very large 95% CI for living situa-
tion, and substantially higher proportions of participation in
samples without adults with ID. Importantly, in individuals
without ID, proportions of living independently were very high
(90%). Surprisingly, regarding tertiary education and remunerative
employment there were no significant differences between mixed
samples and samples without ID, which may indicate that adults
with CP without ID may still be disadvantaged in these life areas.
Although the sample from the study of Murphy et al used in the
meta-analyses of the outcomes walking, education, employment
status, and living situation was not reported to be selected basedwww.archives-pmr.orgon intellectual disability (ie, it was considered a mixed sample),
the results were deviant.77 This might be explained by a large
proportion of the sample classified as dyskinetic (50%), which
usually represent smaller parts of the population.2 Individuals with
dyskinetic CP may have different levels of participation than those
with spastic CP, causing results of this sample to differ.
Overall scores on daily activities and social roles (Life-H) were
close to the cutoff for experiencing difficulty.102,103 These scores
are only estimated based on Dutch samples without ID, which
may limit generalization. Similarly, overall domain scores for
physical functioning and role limitations because of physical
health (SF-36) were low compared with reference values reflecting
limitations in activities and participation.104
Heterogeneity in samples and studies
The high level of statistical heterogeneity, indicating substantial
variation between study results, and the wide confidence intervals
in some of the analyses may partly be explained by sample dif-
ferences. These differences in samples reflect the heterogeneity of
the population with CP, of which the definition is an umbrella
term.1 Previous studies found associations between CP severity
and many of the described outcomes.8,12,14,95 Because of the
available information, we were unable to disentangle differences
in outcomes for other determinants (eg, level of motor function,
age, or region) than mixed samples and samples without ID. We
recommend future studies to systematically report overall results
for subgroups of adults with CP to improve clinical interpretation.
Moreover, we strongly recommend to further standardize assess-
ments in future research and clinical care for adults with CP.
Examples of presently ongoing standardization in this field are
improving the uniformity of registries105,106 and extending them
into the adult population,23 developing core outcome sets for
specific outcomes,107 and creating an overarching ICF core set for
adults with CP.6
Study limitations
The literature search we conducted was very comprehensive, with
386 English-language publications on adults with CP reporting
outcomes of functioning identified by screening more than 6000
records from the database searches. However, some publication
bias may be present because we omitted non-English language
publications, which comprised less than 10% of the eligible pub-
lications. Another source of publication bias might be inconclusive
trials that were not published. We expect this source of publication
bias to be negligible because the outcomes we studied were non-
comparative,108 and intervention trials in adults with CP are very
Fig 2 Forest plots of main outcomes of activities and participation. (A) Walking status; (B) manual ability; (C) education status;
(D) employment status; (E) living situation.
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Epidemiology of CP in adulthood 9scarce, addressing only 5% of the included studies.6 Notably, most
of the included studies were conducted in North America, Western
Europe, Asia, or Australia (see table 1), limiting generalizability of
the results to other regions, for example, those with lower re-
sources. Because of limited availability of population-based studies
(eg, registry studies)15 in adults with CP compared with children,
we were unable to restrict the selection of articles to population-
based samples, causing substantial variability in severity ofwww.archives-pmr.orgmotor and intellectual disability between samples (see table 1).
However, the total of all study samples included is considered
representative for the population of adults with CP with the ma-
jority male and with GMFCS I-III and including both mixed and
no ID samples. The mean age of samples was 32 years, indicating
the included articles mainly studied younger adults, and the results
may not be applicable to older adults with CP. Note that we
excluded nonrepresentative samples that were specifically selected
10 M. van Gorp et alin original studies on having a certain impairment. Still, by
including all representative study samples with at least 25 adults
with CP who were relatively representative of (a subgroup of) the
population with CP, we provided the best available knowledge on
the most often studied outcomes in adults with CP. Another limi-
tation of the study may be that we only focused on results that were
reported as outcomes in the original studies, in line with the review
on most studied outcomes of Benner et al,6 thus not including
information that was originally reported on as sample character-
istics, such as level of gross motor functioning, educational level,
or employment status.Conclusions
The present systematic review and meta-analysis provided state-
of-the-art knowledge of the epidemiology of the most studied
outcomes of health status, impairments, activities, and partici-
pation in adults with CP. Epilepsy and asthma are comorbidities
that occur often in adults with CP. Overall, a majority of adults
with CP experience pain, and on average adults with CP are
fatigued. A majority of adults with CP are ambulant and have
little or no difficulty in manual ability. A minority of the total
population are employed or live independently, with much
higher proportions living independently for individuals without
ID. More uniformity in assessment and reporting is advised to
enable more specified data synthesis on a wider range
of outcomes.Supplier
a. R 3.2.5; R Foundation for Statistical Computing.Keywords
Adult; Cerebral palsy; Epidemiology; Health; Meta-analysis;
Rehabilitation; Systematic review
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